|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$198,559,401 |
|
|
Indirect Value
|
$175,231,488 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 24 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-01-09 |
4 |
B |
$19.00 |
$6,447,992 |
I/I |
339,368 |
952,678 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-06 |
4 |
B |
$18.51 |
$6,311,293 |
I/I |
340,964 |
1,293,642 |
2.25 |
- |
|
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2020-08-26 |
4 |
B |
$4.25 |
$1,552,274 |
I/I |
365,241 |
793,635 |
1.5 |
% |
|
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2020-01-15 |
4 |
A |
$0.00 |
$0 |
I/I |
374,375 |
489,946 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-14 |
4 |
B |
$8.04 |
$3,321,244 |
I/I |
413,090 |
9,098,725 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2014-03-19 |
4 |
S |
$1.91 |
$836,809 |
D/D |
(438,120) |
6,919,392 |
0 |
- |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2008-02-08 |
4 |
D |
$89.50 |
$39,476,123 |
I/I |
(441,074) |
0 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2011-01-11 |
4 |
A |
$13.15 |
$6,246,250 |
D/D |
475,000 |
3,142,288 |
0 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-11-05 |
4 |
B |
$0.77 |
$389,600 |
I/I |
505,974 |
5,314,317 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-10-22 |
4 |
B |
$0.92 |
$498,047 |
I/I |
541,355 |
4,721,022 |
1.5 |
- |
|
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2019-03-14 |
4 |
B |
$1.21 |
$668,492 |
I/I |
552,427 |
3,822,908 |
1.5 |
- |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2008-01-23 |
4 |
OE |
$8.94 |
$7,286,144 |
D/D |
562,666 |
2,806,765 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2014-05-02 |
4 |
OE |
$16.80 |
$9,868,337 |
I/I |
587,401 |
9,776,920 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2016-02-09 |
4 |
B |
$11.86 |
$7,116,000 |
I/I |
600,000 |
11,955,586 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2014-03-21 |
4 |
S |
$1.79 |
$1,143,164 |
D/D |
(638,639) |
6,165,261 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-12 |
4 |
A |
$8.04 |
$5,166,753 |
I/I |
642,631 |
8,685,635 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2019-01-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
689,355 |
0 |
0 |
- |
|
AWH |
Aspira Womens Health Inc |
|
|
2020-06-09 |
4 |
OE |
$1.80 |
$1,315,008 |
I/I |
730,560 |
23,108,802 |
0 |
- |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2023-08-15 |
4 |
B |
$0.65 |
$497,250 |
I/I |
765,000 |
1,637,956 |
0.01 |
% |
|
AWH |
Aspira Womens Health Inc |
10% Owner |
|
2015-07-17 |
4 |
B |
$1.96 |
$1,500,004 |
I/I |
765,308 |
2,053,647 |
1.5 |
- |
|
AWH |
Aspira Womens Health Inc |
|
|
2017-08-31 |
4 |
OE |
$1.00 |
$773,003 |
I/I |
773,003 |
3,905,223 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2012-03-02 |
4 |
B |
$3.33 |
$2,653,754 |
D/D |
796,923 |
6,954,144 |
2.45 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2014-05-19 |
4 |
A |
$16.80 |
$14,499,610 |
I/I |
863,072 |
10,639,992 |
0 |
- |
|
AWH |
Aspira Womens Health Inc |
|
|
2017-02-13 |
4 |
B |
$1.40 |
$1,363,713 |
I/I |
974,081 |
3,132,220 |
2.64 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-11-29 |
4 |
B |
$5.00 |
$5,000,000 |
I/I |
1,000,000 |
18,284,913 |
2.25 |
% |
|
634 Records found
|
|
Page 24 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|